Get the full picture
Sign in to uncover key details.
Illumina Ventures
Finance · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
200 Lincoln Centre Dr Ste 300A, Foster C...Website
www.illuminaventures.comRevenue
<$5 MillionIndustry
About Illumina Ventures
Illumina Ventures is a leader in genomics and precision health investing, focused on building an ecosystem that translates investment into innovation to enhance human health. The company supports various portfolio companies that are advancing life science research, biopharmaceutical drug development, and gene editing technologies. Their intended clients include researchers and organizations in the life sciences and healthcare sectors. Illumina Ventures aims to accelerate impactful solutions in the field of genomics.Explore more
Illumina Ventures Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Illumina Ventures
Compare insights from companies similar to Illumina Ventures, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Illumina Ventures Tech Stack
A closer look at the technologies used by Illumina Ventures
Top Finance Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Illumina Ventures
Sign Up For FreeTo access detailed company insights
Illumina Ventures is a leader in genomics and precision health investing, focused on building an ecosystem that translates investment into innovation to enhance human health. The company supports various portfolio companies that are advancing life science research, biopharmaceutical drug development, and gene editing technologies. Their intended cl... Read More
